IP Library › Assignment 023854/0563
Patent Assignment
Reel/Frame 023854/0563

Change of Name

Recorded: 2010-01-27 Pages: 29
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties (210)
Diphenyl Substituted Alkanes
Antidiabetic Bicyclic Compounds
Bicyclic Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
24-And 25-Substituted Avermectin and Milbemycin Derivatives
Patent: 5,830,875 →
Application: 07/429,919 →
Food Package Hydroxyiminoerythromycin A
Patent: 5,912,331 →
Application: 07/669,809 →
Assays for Agonists and Antagonists of Recombinant Human Calcium Channels
Patent: 5,429,921 →
Application: 07/745,206 →
Slow Release Syneresing Polymeric Drug Delivery Device
Patent: 5,411,737 →
Application: 07/776,913 →
Calcium Channel Alpha-2 Subunit Dnas and Cells Expressing Them
Patent: 5,407,820 →
Application: 07/914,231 →
Human Neuronal Nicotinic Acetylcholine Receptor Compositions and Methods Employing Same
Patent: 5,981,193 →
Application: 07/938,154 →
Prostaglandin Analog for Treating Osteoporosis
Patent: 5,409,911 →
Application: 07/944,149 →
Brain Derived and Recombinant Acidic Fibroblast Growth Factor
Patent: 5,401,832 →
Application: 07/951,365 →
Process of Making Chiral 2-Aryl-1,4-Butanediamine Derivatives as Use- Ful Neurokinin-a Antagonists
Patent: 5,391,819 →
Application: 07/954,215 →
Novel Process for Purification of Hepatitis a Virions
Patent: 5,521,082 →
Application: 07/967,920 →
Hiv Protease Inhibitors Useful for the Treatment of Aids
Patent: 5,413,999 →
Application: 08/059,038 →
Nucleic Acids Encoding Human Metabotropic Glutamate Receptors
Patent: 5,521,297 →
Application: 08/072,574 →
Methods of Treating and Androgenic Alopecia with Finasteride
Patent: 5,571,817 →
Application: 08/094,815 →
Benzo-Fused Lactams Promote Release of Growth Hormone
Patent: 5,430,144 →
Application: 08/097,146 →
Benzo-Fused Lactams Promote Release of Growth Hormone
Patent: 5,434,261 →
Application: 08/097,149 →
Assay for Evaluating Inhibition of Polymorphonuclear Leukocyte Elastase by N-Substituted Azetidinones
Patent: 5,420,010 →
Application: 08/100,532 →
Human Neurokinin-1 Receptor
Patent: 5,484,886 →
Application: 08/117,965 →
Glycosidation Route to 4"-Epi-Methylamino-4"-Deoxyavermectin B1
Patent: 5,399,717 →
Application: 08/129,296 →
Histamine H3-Receptor Antagonists and Therapeutic Uses Thereof
Patent: 5,486,526 →
Application: 08/145,903 →
Antiparasitic Agents
Patent: 5,399,582 →
Application: 08/146,638 →
Spiro Piperidines and Homologs Which Promote Release of Growth Hormone
Patent: 5,536,716 →
Application: 08/147,226 →
Dna Encoding Inducible Nitric Oxide Synthase
Patent: 5,766,909 →
Application: 08/147,812 →
Dna Encoding Human Calcium Channel Alpha-1A, Beta-1, Beta-2, and Beta-4 Subunits, and Assays Using Cells That Express the Subunits
Patent: 5,874,236 →
Application: 08/149,097 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent: 5,591,737 →
Application: 08/168,903 →
Process for Synthesizing Carbapenem Intermediates Using a Rhodium Catalyst and Lewis Acid
Patent: 5,493,018 →
Application: 08/186,207 →
Process for Making Hiv Protease Inhibitors
Patent: 5,463,067 →
Application: 08/187,664 →
A Protein Prenyltransferase
Patent: 5,789,558 →
Application: 08/188,277 →
Cysteine-Modified Acidic Fibroblast Growth Factor and Methods of Use
Patent: 5,409,897 →
Application: 08/189,230 →
Process for Making Avermectin/Zein Compositions
Patent: 5,436,355 →
Application: 08/191,824 →
Human Calcium Channel ALPHA1, ALPHA2, and Beta Subunits and Assays Using Them
Patent: 5,846,757 →
Application: 08/193,078 →
Process for Production of an Antibiotic Compound with Zalerion Arboric Ola
Patent: 5,426,038 →
Application: 08/195,426 →
Fk-506 Cytosolic Binding Protein, FKBP12.6
Patent: 5,457,182 →
Application: 08/197,795 →
Short Synthesis of 5,6-Dihydro-(S)-4-(Ethylamino)-(S)-6-[C3H3]-4H-Thieno[2,3-B]Thiopyran- 2-Sulfonamide 7,7-Dioxide and Related Non Radioactive Compounds
Patent: 5,441,722 →
Application: 08/198,248 →
Inhibitors of Farnesyl-Protein Transferase
Patent: 5,439,918 →
Application: 08/212,489 →
Method of Treating Androgenic Alopecia with 5-Alpha Reductase Inhibitors
Patent: 5,547,957 →
Application: 08/214,905 →
Human Calcium Channel Alpha-Ig/Alpha-Id, Alpha-2, Beta-1, and Gamma Subunits
Patent: 5,851,824 →
Application: 08/223,305 →
Dna Encoding Bradykinin B1 Receptor
Patent: 5,712,111 →
Application: 08/229,418 →
Alendronate Therapy to Prevent Loosening of, or Pain Associated with, Orthopedic Implant Devices
Patent: 5,646,134 →
Application: 08/230,670 →
Human N-Methyl-D-Aspartate Receptor Subunits, Nucleic Acids Encoding Same and Uses Therefor
Patent: 5,849,895 →
Application: 08/231,193 →
Dna Encoding a Soluble Vegf Inhibitor
Patent: 5,712,380 →
Application: 08/232,538 →
Active Avermectin Analogue
Patent: 5,578,581 →
Application: 08/233,489 →
Automated Analysis Equipment and Assay Method for Detecting Cell Surface Protein and/or Cytoplasmic Receptor Function Using Same
Patent: 5,670,113 →
Application: 08/244,985 →
Oral Liquid Alendronate Formulations
Patent: 5,462,932 →
Application: 08/245,289 →
Pneumococcal Polysaccharide Conjugate Vaccine
Patent: 5,623,057 →
Application: 08/246,394 →
Bioconversion Products of 27-Hydroxy Avermectin
Patent: 5,478,929 →
Application: 08/247,173 →
Palladium Catalyzed Ring Closure of Triazolyltryptamine
Patent: 5,567,824 →
Application: 08/248,288 →
Dna Encoding Glutamate Gated Chloride Channels
Patent: 5,527,703 →
Application: 08/249,112 →
Process of Synthesizing Binaphthyl Derivatives
Patent: 5,399,771 →
Application: 08/252,306 →
Process for Recovery and Recycle of Methanesulfonic Acid and Phosphorous Acid
Patent: 5,589,691 →
Application: 08/254,213 →
Histamine H3-Receptor Antagonists and Therapeutic Uses Thereof
Patent: 5,633,382 →
Application: 08/259,926 →
Expression Cassettes Useful in Construction of Integrative and Replicative Expression Vectors for Streptomyces
Patent: 5,622,866 →
Application: 08/264,861 →
Non-Streaming Ophthalmic Tip and Delivery Device
Patent: 5,464,122 →
Application: 08/265,351 →
Reduction of Phenylalkyl Ketones to the Corresponding (S)-Hydroxy Deri Vatives Using Mucor Hiemalis Ifo 5834
Patent: 5,427,933 →
Application: 08/277,727 →
Process for Producing N-Amino-1-Hydroxy-Alkylidene-1, 1-Bisphosphonic Acids
Patent: 5,510,517 →
Application: 08/286,151 →
Novel Process for the Preparation of Diisopinocampheylchloroborane
Patent: 5,545,758 →
Application: 08/289,077 →
Intravenous Alendronate Formulations
Patent: 5,780,455 →
Application: 08/296,192 →
Bioconversion Process for the Synthesis of Transhydroxy Sulfone by Rho Dotorula Rubra or Rhodotorula Piliminae
Patent: 5,474,919 →
Application: 08/305,110 →
Production of Insulin-Like Growth Factor-1 in Methylotrophic Yeast Cells
Patent: 5,612,198 →
Application: 08/308,196 →
Assays of Cells Expressing Human Calcium Channels Containing ALPHA1BET a Subunits
Patent: 5,876,958 →
Application: 08/311,363 →
4-[4'-Piperodinyl or 3'-Pirrolidinyl] Substituted Imidazoles as H3- Receptor Antagonists and Therapeutic Uses Thereof
Patent: 5,639,775 →
Application: 08/313,282 →
Method for Finding Transcription Activators of the Ner Steroid Hormone Receptor
Patent: 5,679,518 →
Application: 08/330,283 →
Defined Medium Ompc Fermentation Process
Patent: 5,494,808 →
Application: 08/332,195 →
Pour-On Formulations Containing Polymeric Material
Patent: 5,516,761 →
Application: 08/333,936 →
Process for Attenuated Varicella Zoster Virus Vaccine Production
Patent: 5,607,852 →
Application: 08/347,345 →
Antiparasitic Agents
Patent: 5,614,546 →
Application: 08/359,666 →
Controlled Release Drug Suspension Delivery Device
Patent: 5,582,838 →
Application: 08/363,451 →
Peptide and Peptide Analog Protease Inhibitors
Patent: 5,804,560 →
Application: 08/369,422 →
Process for the Preparation of 1-(Thiomethyl)-Cyclopropaneacetic Acid
Patent: 5,523,477 →
Application: 08/376,715 →
Process for Preparing Certain Aza Cyclohexapeptides
Patent: 5,552,521 →
Application: 08/386,618 →
Screening Assay Using Cells Expressing Recombinant Alpha and Beta Subunits of the Mammalian Large-Conductance ("Maxi-K") Potassium Channel
Patent: 5,637,470 →
Application: 08/389,668 →
Anthelmintic Use of Nodulisporic Acid and Analogs Thereof
Patent: 5,595,991 →
Application: 08/406,447 →
Hiv Protease Inhibitors Useful for the Treatment of Aids
Patent: 5,527,799 →
Application: 08/407,740 →
Nucleic Acids Encoding and Method for Detecting Nucleic Acid Encoding Human Metabotripic Glutamate Receptor Subtye MGLUR6
Patent: 5,912,122 →
Application: 08/407,875 →
Dna Encoding Human Papillomavirus Type 18
Patent: 5,840,306 →
Application: 08/408,669 →
Recombinant Human Papillomavirus Type 18 Vaccine
Patent: 5,820,870 →
Application: 08/409,122 →
Dual Jet Crystallizer Apparatus
Patent: 5,578,279 →
Application: 08/411,614 →
A Process for the Production of Finasteride
Patent: 5,652,365 →
Application: 08/411,685 →
A Stable, Ready-to-Use Pharmaceutical Paste Composition Containing Proton Pump Inhibitors
Patent: 5,708,017 →
Application: 08/416,275 →
Substituted Pyridines Useful as Modulators of Acetylcholine Receptors
Patent: 5,585,388 →
Application: 08/419,597 →
Ophthalmic Package and Delivery Device
Patent: 5,624,057 →
Application: 08/432,500 →
Enzymatic Hydrolysis of 3,3-Diethyl-4-[(4-Carboxy)Phenoxy]-2-Azetidinone Esters
Patent: 5,523,233 →
Application: 08/433,586 →
Dna Encoding Glutamate Gated Chloride Channels
Patent: 5,693,492 →
Application: 08/435,933 →
Process for the Preparation of Leukotriene Antagonists
Patent: 5,614,632 →
Application: 08/439,733 →
Genes Which Influence Pichia Proteolytic Activity, and Uses Therefor
Patent: 5,691,166 →
Application: 08/441,750 →
Genes Which Influence Pichia Proteolytic Activity, and Uses Therefor
Patent: 5,831,053 →
Application: 08/441,751 →
Methods of Treating Neurodegenerative Disorders Using Protease Inhibitors
Patent: 5,872,101 →
Application: 08/444,361 →
Methods of Treating Neurodegenerative Disorders Using Protease Inhibitors
Patent: 5,863,902 →
Application: 08/444,912 →
Substituted Sulfonamides as Selective B3 Agonists for the Treatment of Diabetes and Obesity
Patent: 5,561,142 →
Application: 08/445,630 →
Treatment of Migraine with Morpholine Tachykinin Receptor Antagonists
Patent: 5,716,942 →
Application: 08/450,198 →
Asymmetric Synthesis of (-)6-Chloro-4-Cyclopropyl-Ethynyl-4-Trifluoromethyl-1,4-Dihydro-2H-3,1 -Benzoxanzin-2-One
Patent: 5,633,405 →
Application: 08/450,330 →
Treatment of Emesis with Morphlime Tachykinin Receotor Antagonists
Patent: 5,512,570 →
Application: 08/450,507 →
Methods of Treating Androgenic Alopecia with Finasteride [17B-N-Mono- Substituted-Carbamoyl-4-Aza-5-Alpha-Androst-1-En-Ones]
Patent: 5,567,708 →
Application: 08/455,464 →
Human Calcium Channel Compositions and Methods
Patent: 5,792,846 →
Application: 08/455,543 →
Process for Making Hiv Protease Inhibitors
Patent: 5,491,238 →
Application: 08/458,379 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent: 5,663,169 →
Application: 08/458,528 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent: 5,665,720 →
Application: 08/458,529 →
Process for Making Hiv Protease Inhibitors
Patent: 5,496,948 →
Application: 08/459,069 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent: 5,519,021 →
Application: 08/460,026 →
Dna Encoding the Human Neurokinin-1 Receptor
Patent: 5,525,712 →
Application: 08/463,488 →
16-Substituted-4-Aza-Androstane 5-Alpha-Reductase Isozyme 1 Inhibitors
Patent: 5,719,158 →
Application: 08/463,544 →
Dna and Mrna Encoding an A7 Subunit of a Human Neuronal Nicotinic Acetylcholine Receptor Subunit and Cells Transformed with Same
Patent: 5,837,489 →
Application: 08/466,589 →
Modulators of Acetylcholine Receptors
Patent: 5,703,100 →
Application: 08/485,398 →
Methods for Identifying Compounds That Modulate the Activity of Human N-Methyl-D-Aspartate Receptors
Patent: 5,985,586 →
Application: 08/486,273 →
Substituted Pyridines Useful as Modulators of Acetylcholine Receptors
Patent: 5,852,041 →
Application: 08/486,324 →
Process for Making an Epoxide
Patent: 5,728,840 →
Application: 08/512,602 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent: 5,719,147 →
Application: 08/525,259 →
Morpholine Compounds Are Prodrugs Useful as Tachykinn Receptor Antagonists
Patent: 5,691,336 →
Application: 08/525,870 →
Combination of an Ace Inhibitor and a Diuretic
Patent: 5,686,451 →
Application: 08/526,142 →
Human A3 Adenosine Receptors
Patent: 5,817,760 →
Application: 08/560,231 →
Pour-On Formulations Consisting of Gylcols,Glycerides and Avermectin Compounds
Patent: 5,602,107 →
Application: 08/561,208 →
Culture Medium for Saccharomyces Cerevisiae
Patent: 5,795,771 →
Application: 08/578,719 →
Novel Process for the Preparation of Diisopinocampheylchloroborane
Patent: 5,693,816 →
Application: 08/586,037 →
Method of Treating Androgenic Alopecia with 5-Alpha Reductase Inhibitors
Patent: 5,824,686 →
Application: 08/596,339 →
16-Substituted-4-Aza-3-Oxo-Androstane as 5--Alpha-Reductase Isozyme 1 Inhibitors
Patent: 5,739,137 →
Application: 08/601,042 →
Dna Encoding 1,3 Beta-D Glucan Synthase Subunits
Patent: 5,821,353 →
Application: 08/619,554 →
Dna Encoding Triol Polyketide Synthase
Patent: 5,849,541 →
Application: 08/637,640 →
Imidazolinobenzodiazepines
Patent: 5,834,464 →
Application: 08/640,730 →
A Novel Human Steroid Receptor and Dna
Patent: 5,939,322 →
Application: 08/646,248 →
Asymmetric Synthesis of (-)6-Chloro-4-Cyclopropyl-Ethynyl-4- Trifluoromethyl-1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Patent: 5,698,741 →
Application: 08/680,940 →
Process for Synthesizing Carbapenem Side Chain Intermediates
Patent: 5,648,501 →
Application: 08/681,025 →
Triazolylmethyl-Indole Ethylamine Bisulfate Salt
Patent: 5,834,502 →
Application: 08/682,815 →
Synthetic HPV11 Virus-Like Particles
Patent: 5,795,754 →
Application: 08/683,991 →
2,5-Substituted Aryl Pyrroles, Compositions Containing Such Compounds and Methods of Use
Patent: 5,837,719 →
Application: 08/694,143 →
Production of Recombinant Human Papillomavirus Type Ii Protein Utilizing Papillomavirus 6/11 Hybrid Dna
Patent: 5,821,087 →
Application: 08/710,082 →
Method for Analyzing the Immunosuppressant Activity of Ion Channel Blockers Using the Mini-Pig
Patent: 5,837,220 →
Application: 08/711,576 →
Cyclopentyl Tachykinin Receptor Antagonists
Patent: 5,750,549 →
Application: 08/730,277 →
Triterpene Derivatives with Immunosuppressant Activity
Patent: 5,883,119 →
Application: 08/733,032 →
Synthetic HPV11 Virus-Like Particles
Patent: 5,738,853 →
Application: 08/738,509 →
Substituted Pyridyl Pyrroles, Compositions Containing Such Compounds and Methods of Use
Patent: 5,776,954 →
Application: 08/742,428 →
Piperazine Compounds Promote Release of Growth Hormone
Patent: 5,777,112 →
Application: 08/750,759 →
Nolynucleotide Vaccine for Papillomavirus
Patent: 5,866,553 →
Application: 08/750,810 →
Gender-Specific Fading Down Turkey Breed
Patent: 5,959,172 →
Application: 08/757,497 →
Hiv Protease Inhibitors Useful for the Treatment of Aids
Patent: 5,717,097 →
Application: 08/759,203 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent: 5,952,321 →
Application: 08/764,775 →
Radiolabeled Growth Hormone Secretagogue
Patent: 5,830,433 →
Application: 08/768,368 →
Piperidines and Hexahydro-1H-Azepines Spiro Substituted at the 4-Position Promote Release of Growth Hormone
Patent: 5,783,582 →
Application: 08/776,041 →
Process for Synthesizing Carbapenem Side Chain Intermediates
Patent: 5,721,368 →
Application: 08/783,253 →
Inhibitro of Vascular Endothelial Cell Growth Factor
Patent: 5,861,484 →
Application: 08/786,164 →
Antidiabetic Agents
Patent: 5,859,051 →
Application: 08/791,213 →
Capped Synthetic Rna, Analogs, and Aptamers
Patent: 5,861,501 →
Application: 08/807,104 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent: 5,811,423 →
Application: 08/815,780 →
Controlled Release Simvastatin Delivery Device
Patent: 5,882,682 →
Application: 08/817,129 →
Benzo-Fused Lactams Promote Release of Growth Hormone
Patent: 5,968,924 →
Application: 08/820,302 →
Finasteride Processes
Patent: 5,886,184 →
Application: 08/824,426 →
Carbapenem Antibacterial Compounds, Compositions Containing Such Compounds and Methods of Treatment
Patent: 5,756,725 →
Application: 08/825,786 →
Inhibitors of Farnesyl-Protein Transferase
Patent: 5,854,264 →
Application: 08/826,251 →
Piperidines, Pyrrolidines and Hexahydro-1H-Azepines Promote Release Ofgrowth Hormone
Patent: 5,804,578 →
Application: 08/828,606 →
Irreversible Inhibition of Human 5-X-Reductase
Patent: 5,962,442 →
Application: 08/836,341 →
Substituted 2-Aminopyridines as Inhibitors of Nitric Oxide Synthase
Patent: 5,972,975 →
Application: 08/836,953 →
Alpha V Beta 3 Antagonists
Patent: 5,925,655 →
Application: 08/841,979 →
Antibacterial Agents
Patent: 5,925,659 →
Application: 08/845,291 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent: 5,747,485 →
Application: 08/848,076 →
Effervescent Alendronate Formulation
Patent: 5,853,759 →
Application: 08/848,460 →
Alpha 1A Adrenergic Receptor Antagonists
Patent: 5,952,351 →
Application: 08/860,314 →
Novel Chiral Bisphosphines
Patent: 5,874,629 →
Application: 08/866,665 →
Substituted Imidazoles Having Cytokine Inhibitory Activity
Patent: 5,859,041 →
Application: 08/871,382 →
Process for Preparing Certain Aza Cyclohexapeptides
Patent: 5,936,062 →
Application: 08/874,118 →
Process of Preparing Phenyl Heterocycles Useful as Cox-2 Inhibitors
Patent: 5,840,924 →
Application: 08/876,894 →
Process for Synthesizing Carbapenem Antibiotics
Patent: 5,872,250 →
Application: 08/887,849 →
Morpholine Compounds Are Prodrugs Useful as Tachykinin Receptor Antagonists
Patent: 5,780,467 →
Application: 08/907,738 →
Palladium Catalyzed Indolization
Patent: 5,808,064 →
Application: 08/908,683 →
Integrin Antagonists
Patent: 5,981,546 →
Application: 08/912,761 →
Antiparasitic Agents
Patent: 5,834,260 →
Application: 08/914,998 →
Purified Bradykinin B1 Receptor
Patent: 5,965,367 →
Application: 08/932,761 →
Detergent-Free Hepatitis C Protease
Patent: 5,861,297 →
Application: 08/936,865 →
Rotavirus Vaccine Formulations
Patent: 5,932,223 →
Application: 08/938,260 →
Synthetic HPV16 Virus-Like Particles
Patent: 5,922,588 →
Application: 08/943,583 →
Dry Mix Formulation for Bisphosphonic Acids
Patent: 5,882,656 →
Application: 08/946,849 →
Triterpene Derivatives with Immunosuppressant Activity
Patent: 5,874,594 →
Application: 08/947,307 →
Method of Treating Colonic Adenomas
Patent: 5,968,974 →
Application: 08/948,873 →
Conjugates Useful in the Treatment of Prostate Cancer
Patent: 5,948,750 →
Application: 08/950,805 →
Heteroaryl Spiroethercycloalkyl Tachykinin Receptor Antagonists
Patent: 5,929,094 →
Application: 08/956,181 →
Process for the Crystallization of Losartan
Patent: 5,859,258 →
Application: 08/959,209 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent: 5,872,116 →
Application: 08/959,393 →
Nucleic Acids Encoding a Truncated Mouse Beta Integrin Subunit
Patent: 5,895,754 →
Application: 08/960,387 →
Combination Therepy for the Treatment of Diabetes and Obesity
Patent: 5,908,830 →
Application: 08/961,749 →
Recombinant Papillomavirus Vaccines
Patent: 5,888,516 →
Application: 08/969,523 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent: 5,922,706 →
Application: 08/969,685 →
Process for Making Capsular Polysaccharides from Streptococcus Pneumoniae
Patent: 5,847,112 →
Application: 08/970,460 →
Anhydrous Alendronate Monosodium Salt Formulations
Patent: 5,849,726 →
Application: 08/973,386 →
Alpha La Adrenercic Receptor Antagonists
Patent: 5,977,115 →
Application: 08/973,624 →
Methods and Compositions for Preventing and Treating Bone Loss
Patent: 5,945,412 →
Application: 08/984,425 →
Synthetic Hpv 16 Virus-Like Particles
Patent: 5,952,216 →
Application: 08/987,519 →
Promote Release of Growth Hormone
Patent: 5,965,565 →
Application: 08/988,816 →
Spiro-Substituted Azacycles as Modulators of Chemokine Receptor Activity
Patent: 5,962,462 →
Application: 08/989,947 →
Effiecient Synthesis of a Chiral Mediator
Patent: 5,856,492 →
Application: 09/002,853 →
Process for the Crystallization of a Reverse Transcriptase Inhibitor Using an Anti-Solvent
Patent: 5,965,729 →
Application: 09/008,824 →
Process for 3-(2-(7-Chloro-2-Quinolinyl)Ethenyl)- Benzaldehyde
Patent: 5,869,673 →
Application: 09/012,283 →
Intravenous Alendronate Formulations
Patent: 5,843,924 →
Application: 09/033,015 →
Quinoline Leukotriene Antagonists
Patent: 5,952,347 →
Application: 09/037,949 →
Nodulisporic Acid Derivatives
Patent: 5,962,499 →
Application: 09/046,052 →
Sodium Alendronate Preparation for Local Administration
Patent: 5,958,908 →
Application: 09/059,555 →
Carbapenem Antibotic, Composition and Method of Preparation
Patent: 5,952,323 →
Application: 09/064,426 →
Intravenous Alendronate Formulations
Patent: 5,914,323 →
Application: 09/072,602 →
Alendronate Therapy to Prevent Loosening of, or Pain Associated with, Orthopedic Implant Devices
Patent: 5,972,913 →
Application: 09/082,237 →
Novel Process for Indinavir Intermediate
Patent: 5,981,759 →
Application: 09/098,776 →
Crystalline Forms of Antibiotic Side Chain Intermediates
Patent: 5,965,747 →
Application: 09/102,449 →
Composition and Method for Preventing Pine Wilting Disease
Patent: 5,945,445 →
Application: 09/109,190 →
4-Cyano-4-Deformylsordarin Derivatives
Patent: 5,972,996 →
Application: 09/123,230 →
4-Cyano-4-Deformylsordaricin Derivatives
Patent: 5,965,612 →
Application: 09/123,236 →
Insulin Sensitivity with Angiotensin Ii Receptor Blocking Imidazoles
Patent: 5,962,500 →
Application: 09/128,138 →
Process for Enhancing the Optical Purity
Patent: 5,952,528 →
Application: 09/145,667 →
Antiparasitic Agents
Patent: 5,945,317 →
Application: 09/157,862 →
Prevention of Precipitated Acute Urinary Retention
Patent: 5,942,519 →
Application: 09/178,138 →
Method for Treating or Preventing Psychosomatic and Psychoimmunologic
Patent: 5,972,938 →
Application: 09/199,370 →
Methods of Using Saha and Bortezomib for Treating Multiple Myeloma
Application: 12/312,163 →
Publication: US 2010/0113392
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Aug 17, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028804/0321 →
Change of Name Aug 17, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028804/0559 →
Merger Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Assignment of Assignor's Interest Jul 16, 2014
From: MERCK SHARP & DOHME CORP.
To: MERIAL LIMITED
Reel/Frame 033323/0013 →